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Edited by David LambethAbstract We hypothesized that in marginal thiamin deﬁciency
intracellular a-oxoaldehydes form macromolecular adducts that
could possibly be genotoxic in colon cells; and that in the pres-
ence of oxidative stress these eﬀects are augmented because of
decreased detoxiﬁcation of these aldehydes. We have demon-
strated that reduced dietary thiamin in F344 rats decreased
transketolase activity and increased a-oxoaldehyde adduct lev-
els. The methylglyoxal protein adduct level was not aﬀected by
oral glyoxal or methylglyoxal in the animals receiving thiamin
at the control levels but was markedly increased in the animals
on a thiamin-reduced diet. These observations are consistent with
our suggestion that the induction of aberrant crypt foci with mar-
ginally thiamin-deﬁcient diets may be a consequence of the for-
mation of methylglyoxal adducts.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Thiamin (vitamin B1) in its diphosphate form (TDP) is an
important coenzyme for transketolase (TK), pyruvate dehy-
drogenase, a-ketoglutarate dehydrogenase and the branched-
chain a-ketoglutarate dehydrogenase complex. These enzymes
are involved in the maintenance of NADPH levels and carbo-
hydrate metabolism in the cell (Scheme 1) [1,2]. Thornalley
et al. [3] have shown that accumulation of methylglyoxal
(MG, an a-oxoaldehyde) and triose phosphates in human
red blood cells incubated under hyperglycemic conditions
can be prevented by thiamin. Moreover, Thornalleys group
has recently shown that high dose thiamin and benfotiamine
(lipophilic derivative of thiamin) therapy in diets administered
to streptozotocin induced diabetic rats prevented incipient
diabetic nephropathy induced by reactive a-oxoaldehyde [4].Abbreviations: MG, methylglyoxal; TK, transketolase; TPP, thiamin
pyrophosphate; RBC, red blood cells; ACF, aberrant crypt foci; AGEs,
advanced glycation end-products
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doi:10.1016/j.febslet.2005.09.027MG is formed by the non-ezymatic elimination of phosphate
from the triosephosphates glyceraldehyde-3-phosphate and
glycerone phosphate, as well as enzymatically from dihydroxy-
acetone phosphate catalyzed by the allosterically regulated
MG synthase [5,6]. It is also formed via ketone body metabo-
lism from acetone, and by the metabolism of threonine [7].
Glyoxal (MG derivative), however, is a product of lipid perox-
idation, ascorbate autoxidation, oxidative degradation of glu-
cose and glycated proteins [8]. MG and glyoxal are
bifunctional alkylating agents that react with free amino and
thiol groups of biomolecules, resulting in the formation of ad-
vanced glycation end-products (AGEs). Glyoxal and MG react
non-enzymatically and reversibly with lysine, arginine and cys-
teine residues of proteins [9,8]. Irreversible reactions with ly-
sine and arginine result in glyosylamine protein crosslinks
and imidazolone (Scheme 2) derivatives, respectively [10].
Although glyoxal and MG have not been classiﬁed as carcin-
ogens [11], they appear to be tumor promoters and have been
shown to be direct mutagens in several cellular models [12]. In
studies done with rat liver microsomal fractions (S9) or thiol
compounds, the mutagenic activity of these compounds was
abolished [13,14]. Therefore, the mutagenic expression of these
compounds may be ameliorated by cellular antioxidant and
metabolic capacity.
MG and glyoxal are detoxiﬁed endogenously primarily by the
glyoxalase system, which converts glyoxal to glycolate in the
presence of glutathione (GSH) [15]. Another minor detoxiﬁca-
tion pathway for glyoxal is catalyzed by oxido-reductases.
The family of oxido-reductases involves the enzymes usually
represented as ALR1, ALR2 and ALR3, and are called alde-
hyde reductase, aldose reductase and carbonyl reductase,
respectively. These enzymes have a broad substrate speciﬁcity,
are located in the cytosol and require NADPH or NADH to
a lesser degree as a co-factor [16]. Under conditions of oxidative
stress, the level of GSH decreases and this impairs glyoxal and
MG detoxiﬁcation by the glyoxalase system [15]. On the other
hand thiamin deﬁciency aﬀects the metabolism of these species
via the oxido-reductase pathway due to a decrease in NADPH
levels that eventually causes a decrease in GSH levels [17].
Therefore, it appears that oxidative stress and thiamin deﬁ-
ciency have an overlapping requirement for NADPH andGSH.
Recently, we reported that thiamin deﬁciency in Fischer 344
rats induced the formation of aberrant crypt foci (ACF, puta-
tive precursors of colon cancer) [18] in the absence of clinical
beriberi symptoms. Furthermore, thiamin deﬁciency in mam-
malian cells in vitro markedly increased hepatocyte susceptibil-ation of European Biochemical Societies.
Scheme 1. Proposed mechanism of synergism between oxidative stress (i.e., MG and glyoxal) and thiamin deﬁciency. Thiamin deﬁciency causes a
decrease in the activity of thiamin-dependent enzymes such as tranketolase (TK), pyruvate dehydrogenase, branched chain ketoacid dehydrogenase
and a-ketoglutarate dehydrogenase (). The decrease in TK activity causes a decrease in cellular NADPH levels. Under conditions of thiamin
deﬁciency and oxidative stress the detoxiﬁcation mechanisms of glyoxal and MG are decreased (·) due to lower levels of glutathione (GSH) and
NADPH. The decrease in glyoxal and MG detoxiﬁcation leads to an increase in their protein adducts. AKR, aldose-ketose reductase; DHAP,
dihydroxyacetone phosphate; GA3P, glyceraldehyde-3-phosphate and TPI, triosephosphate isomerase.
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ciency MG and glyoxal form macromolecular adducts, and
this can result in genotoxicity in colon cells. In the presence
of an oxidative stress, these eﬀects are augmented because of
decreased detoxiﬁcation of these aldehydes. As a ﬁrst step in
testing this suggestion, we examined the eﬀect of thiamin deﬁ-
ciency and oxidative stress (introduced in the form of glyoxal
and MG) on hydroimidazolone adduct (Scheme 1) formation
in plasma proteins.
In this study, we report that reduced dietary thiamin de-
creased TK activity and increased a-oxoaldehyde adduct lev-
els. The MG adduct level was not aﬀected by oral glyoxal or
MG in the animals receiving thiamin at the control levels but
was markedly increased in the animals on the thiamin-reduceddiet. These observations are consistent with our suggestion
that the induction of ACF with marginally thiamin-deﬁcient
diets is a consequence of the formation of MG adducts and
suggest that the apparent carcinogenic eﬀect of thiamin deﬁ-
ciency will be increased further in animals exposed to oxidative
stress.2. Materials and methods
Glyoxal (40% w/v), MG (40% w/v), ribose-5-phosphate, 1,2-diami-
nobenzene, perchloric acid (HClO4) were purchased from Sigma–
Aldrich Chemical Co. (St. Louis, MO). Animal diets were prepared
by Research Diets Inc. (New Brunswick, NJ).
Scheme 2. Predominant hydroimidazolone isomers of methylglyoxal
and glyoxal.
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25 male Fischer 344 rats weighing 125–150 g (Harlan Sprague–Daw-
ley) were housed in ventilated plastic cages. Care and treatment of the
rats were in compliance with the guidelines of the Canadian Council on
Animal Care, and the protocol was approved by the University of Tor-
onto Animal Care Committee. The following environmental condi-
tions applied throughout the course of the study; 12 air changes per
hour, 12-h light/day cycle (lights on at 05:00 h), and an ambient tem-
perature of 21–23 C with a 50–60% relative humidity.Table 1
Summary of measurements for body weight at sacriﬁce, food and drink con
Group A B
Study 1: 0.3% glyoxal in drinking water
Thiamin dose 6 mg/kg diet 2.
Drink Water W
Final body weight (g) 316 ± 20.81 33
Food consumption (g/rat/week) 102.6 ± 16.05 10
Water consumption (ml/rat) n/m n/
Estimated dose (mg/kg b.w./day) n/a n/
Study 2: 0.3% MG in the drinking water
Thiamin dose 6 mg/kg diet 2.
Drink Water W
Final body weight (g) 320 ± 15.72 31
Food consumption (g/rat/week) 97.9 ± 6.71 95
Water consumption (ml/rat) 119 ± 13.40 12
Estimated dose (mg/kg b.w./day) n/a n/
Note: n/m = not measured; n/a = not applicable.
aP < 0.001 as compared to groups A and B.
bP < 0.05 as compared to group A.The animals were allowed to acclimatize for one week and were fed a
diet of standard rat chow and water ad libitum. After one week the ani-
mals were randomized and divided into four groups: Group A with se-
ven (7) animals and group B, C and D with six (6) animals each. The
animals in group A were fed AIN-76 control diet containing 6 mg/kg
thiamin (Research diet, New Brunswick, NJ). Group B, AIN-76 thia-
min-deﬁcient diet containing 1.5 mg/kg thiamin. Group C, AIN-76
control diet containing 6 mg/kg thiamin and 0.3% glyoxal in their
drinking water and group D, AIN 76 thiamin-deﬁcient diet containing
1.5 mg/kg thiamin and 0.3% glyoxal in their drinking water. A subse-
quent experiment was performed using 0.3% MG in the drinking water
for groups C and D instead of 0.3% glyoxal.
Actual thiamin levels in the diets stored at 20 C were measured at
the end of the study by HPLC (AOAC (2000) 942.23, 986.27 Silliker
Canada Co. Markham, Canada) were 5.2 and 0.9 mg/kg, respectively.
Animal weight, food and water consumption was monitored weekly
during the course of the experiment.
For both experiments, tail vein blood was collected at 0, 14, 28, 42
and 56 days for analysis of biochemical markers of oxidative stress
(glyoxal/MG levels in the plasma) and thiamin status (TK activity in
red blood cells (RBCs)). At the end of 70 days on the diets, the rats
were anesthetized (CO2 inhalation) and blood was collected by cardiac
puncture for TK activity, MG and glyoxal levels and protein hydroim-
idazolone levels.
2.2. TK activity measurements
RBC TK activity was measured by the protocol outlined by Cham-
berlain et al. [19] on the blood collected via tail vein every 2 weeks and
on the blood collected by cardiac puncture on day 70. Brieﬂy, activity
was measured by adding 20 ll of lysed RBCs to 200 ll reaction mix-
ture containing 14.8 mM ribose-5-phosphate, 253 lM NADH,
185 U/ml triosephosphate isomerase and 21.5 U/ml a-GAPDH (pH
8) in Tris buﬀer. Fluorescence intensity was measured at kexcitation =
325 nm and kemission = 430 nm immediately and then every 10 min for
2 h. The activity was calculated from the diﬀerence in the ﬂuorescence
intensity readings at 10 and 80 min. Percent thiamin pyrophosphate
(TPP) eﬀect (0–15% normal thiamin, 15–25% marginally deﬁcient thi-
amin and >25% thiamin deﬁcient) was calculated as outlined by Cham-
berlain et al. [19,20].
2.3. Glyoxal and MG levels
Glyoxal and MG levels in the plasma were measured as per the
methods outlined by Okado-Matsumoto et al. [21]. A Phenomenex
Luna 5l C18 100A 250 · 4.6 mm column was used. 1,2-Diaminoben-
zene was used as a derivatizing agent for the analysis of glyoxal by iso-
cratic gradient HPLC. To a 1 ml solution of plasma (1:10 dilution of
plasma), 0.2 ml of 5 M HClO4, 0.2 ml of 2,3-dimethylquinoxaline as
an internal standard, 0.2 ml of 10 mM 1,2-diaminobenzene, and water
to a 2-ml ﬁnal volume. After 1 h at 25 C, HPLC analysis was per-sumption
C D
5 mg/kg diet 6 mg/kg diet 2.5 mg/kg diet
ater Glyoxal Glyoxal
0 ± 12.66 259 ± 18.14a 262 ± 20.62a
8.0 ± 16.27 83.2 ± 13.94a 83.6 ± 12.70a
m 135 ± 18.77 131 ± 16.31
a 223.36 214.27
5 mg/kg diet 6 mg/kg diet 2.5 mg/kg diet
ater MG MG
3 ± 6.37 320 ± 10.55 301 ± 13.93b
.6 ± 7.94 96.5 ± 5.97 92.3 ± 4.37
5 ± 13.19 107 ± 6.86b 104 ± 9.05b
a 143.31 148.07
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buﬀer, pH 3.4, and 50% (v/v) methanol. A volume of 100 ll was in-
jected. The ﬂow rate was 1.0 ml/min and quinoxalines were detected
at 315 nm.
2.4. Hydroimidazolone adducts measurements
Plasma levels of hydroimidazolone adducts of MG and glyoxal were
measured at day 70 by quantitative immunoblotting. Dot blots were
performed as per the methods outlined by Shinohara et al. [20,22].
Equal amounts of plasma protein were used for quantitative immuno-
blotting. Methylglyoxal-derived imidazole AGE was detected using a
1:10000 dilution of monoclonal antibody 1H7G5 (generously donated
by Dr. Michael Brownlee, Albert Einstein University, NY). Immuno-
complexes were visualized using an enzyme-catalyzed ﬂuorescence kit
according to the manufacturers instructions (Amersham, Piscataway,
New Jersey) and were quantitated on a FluorChem 8800 (Perkin–El-
mer, Ontario, Canada). A standard of bovine serum albumin (BSA)
modiﬁed with MG and glyoxal was used to quantitate the dot blots
as MG/glyoxal BSA equivalents.
2.5. Statistical analysis
Statistical analysis was preformed by one-way ANOVA.0
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Fig. 1. Eﬀect of glyoxal (A) or methylglyoxal (MG) (B) administration
(p.o.) on rat growth rate. Here animals receiving oral glyoxal but not
MG show signiﬁcant reduction in weight gain after 7 days.3. Results and discussion
We designed this study to investigate the interactions be-
tween marginal thiamin deﬁciency and oxidative stress using
glyoxal and MG as an exogenous model of dietary stress. It
was found that reduced dietary thiamin caused a decrease in
RBC TK activity and an increase in the plasma level of glyoxal
and MG adducts. We also found that oxidative stress aug-
mented the response to thiamin deﬁciency and caused a signif-
icant decrease in TK activity within 2 weeks. Furthermore, it
caused an increase in plasma levels of MG and glyoxal at 10
weeks and increased MG and glyoxal plasma protein adducts.
Table 1 summarizes ﬁnal weight as well as food and water
consumption. Rats given glyoxal in the drinking water had a
signiﬁcant weight reduction as early as the ﬁrst week under test
diet (Fig. 1A) as compared to the control thiamin (5.2 mg/kg)
and thiamin deﬁcient (0.9 mg/kg) groups. This was associated
with the decreased food consumption at the same time (Table
1). Rats given MG in the drinking water did not show any sig-
niﬁcant decrease in weight gain as compared to the control
groups (Fig. 1B). The average dose of glyoxal and MG in-
gested by the animals were 57 and 45 mg/day, respectively,
as assessed by the amount of drinking water consumed, and
were consistent over the duration of the study. When related
to body weight (b.w.) at time of sacriﬁce the above values cor-
respond to an eﬀective dose of 220 and 145 mg/kg b.w./day for
glyoxal and MG, respectively.
RBC TK activity was assessed as a measure of the animals
thiamin status. To assure that the decrease observed was due
to thiamin levels and not modiﬁcation of the TK enzyme,
the percent TPP eﬀect (0–15% normal thiamin, 15–25% mar-
ginally deﬁcient, >25% deﬁcient) was calculated. We found
that reduced dietary thiamin caused a decrease in RBC TK
activity (25%) within two weeks (Fig. 2A and B), which
was further increased to 35% after 4 weeks. However, the ef-
fect on the TK activity was more pronounced with the glyoxal
and MG administered groups. MG and glyoxal both caused a
further decrease in TK activity in the control (MG group 54%
and glyoxal group 45%) and decreased-thiamin groups (MG
group 69% and glyoxal group 70%). The further decrease in
TK activity of the groups with MG and glyoxal could bedue to the induction of oxidative stress. The TK activities of
control groups in these two studies are consistent with those
observed in a previous report [18]. We suggested then that thi-
amin deﬁciency (as measured by reduced TK activity) was a
factor in inducing spontaneous formation of ACF in the rat.
We can therefore hypothesize that further inhibition, as ob-
served here in relation to glyoxal or MG in the diet, will en-
hance the carcinogenic eﬀect. Studies are currently underway
to test this interaction and the signiﬁcance of the various bio-
markers reported here.
In our previous in vitro experiments with isolated rat hepa-
tocyte, we found that glyoxal toxicity could be attributed to
oxidative stress. As before glyoxal-induced cytotoxicity ensued
there was an increase in reactive oxygen species formation, li-
pid peroxidation and a decrease in mitochondrial potential [8].
Thiamin has been shown to inhibit lipid peroxidation in rat
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Fig. 2. Time course of RBC TK activity (A) glyoxal (G) and (B)
methylglyoxal (MG) administered rats. A signiﬁcant reduction in TK
activity was observed at 2 weeks. \n = 6, signiﬁcant as compared to
control thiamin (6 mg/kg) (P < 0.01). Absolute TK activity values at 70
days were 8.37, 6.40, 4.75 and 3.07 lg/mol/ml for groups A, B, C, and
D, respectively, in study (A). They were 8.70, 5.29, 4.16, and 2.92 lg/
mol/ml for groups A, B, C, and D, respectively, in study (B).
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Fig. 3. Time course of plasma glyoxal (G) levels found in (A) glyoxal
and (B) methylglyoxal (MG) administered rats. A signiﬁcant increase
was observed at 70 days. \n = 6, signiﬁcant as compared to control
thiamin (6 mg/kg) (P < 0.03).
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in vitro. Thiamin also interacts with free radicals and hydro-
peroxides and is oxidized to thiochrome and thiamin disulﬁde
[23]. Thiochrome and thiamin disulﬁde cannot be converted to
TDP and be used as a co-factor for carbohydrate metabolizing
enzymes. Thiamin can act as an antioxidant in the cell by suc-
cessively transferring hydrogens from the amino group of the
pyrimidine ring and from the thiazole ring after ring opening
[23]. Therefore, the oxidative stress caused by these reactive
aldehydes could cause a decrease in thiamin which resulted
in a decrease in TK activity.
As shown inFig. 3A, therewas a signiﬁcant increase in plasma
glyoxal levels in the group of rats that were given glyoxal in
the drinking water and had decreased dietary thiamin (plasma
glyoxal levels at 70 days = 1.45 lM). The same increase was
observed in the group of rats given MG in the drinking water
and a decreased dietary thiamin diet (plasma glyoxal levels at
70 days = 1.27 lM) (Fig. 3B). Plasma MG levels (Fig. 4A and
B) for both these groups of animals were also signiﬁcantly
higher as compared to the control groups (MG in drinkingwater and decreased dietary thiamin 2.1 lM and glyoxal in
drinking water and decreased dietary thiamin diet 1.64 lM)
at 70 days. However, the levels of MG and glyoxal did not in-
crease in control diet or decreased dietary thiamin diet or con-
trol diet with MG or glyoxal in the drinking water (Figs. 3 and
4). Therefore, the increase in plasma levels of MG and glyoxal
observed in rats given MG or glyoxal in drinking water and de-
creased thiamin in the diet indicates that the metabolism of
these reactive dialdehydes may be decreased. In our previous
study, we found that under conditions of oxidative stress, gly-
oxal metabolism in hepatocyte was inhibited [8]. As mentioned
earlier, thiamin deﬁciency and a-oxoaldehyde metabolism/oxi-
dative stress have overlapping requirements for GSH and
NADPH. GSH not only forms the primary defense mechanism
of the cell against oxidative stress, but is essential for glyoxal
and MG metabolism by the glyoxalase system [15]. However,
when the concentration of GSH decreased below 3 mM in
the liver, (normally 15 mM) the NAD[P]H dependent oxido-
reductase system became the primary detoxiﬁcation mecha-
nism for these a-oxoaldehydes [24]. Thiamin deﬁciency by
inhibiting TK aﬀects the pentose phosphate pathway a major
supplier of NADPH in the cell, which would compromise
the MG and glyoxal detoxifying reductases (Scheme 1) [1].
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ated with an increase in the intracellular protein adducts
(Fig. 5) as measured by the monoclonal antibody against
MG/glyoxal hydroimidazolone adduct. A signiﬁcant increase
in adducts was observed at 70 days in the rats with thiamin
deﬁciency and oxidative stress (MG group = 1.19 and glyoxal
group = 1.14 BSA equivalent). In a similar study, we looked
at the eﬀects of N-acetylcysteine supplementation (precursor
for GSH formation and antioxidant) on the level of these pro-
tein adducts under conditions of thiamin deﬁciency and oxida-
tive stress. We found that the level of adducts in the groups
given 0.3% N-acetylcysteine (in the drinking water) decreased
approximately 3-fold under conditions of thiamin deﬁciency
alone or glyoxal/MG-induced oxidative stress (paper in prepa-
ration). We also currently have studies underway with N-ace-
tylcysteine plus thiamin deﬁciency and MG/glyoxal as
exogenous sources of oxidative stress to further establish thisrelationship between the increase in plasma hydroimidazolone
adducts and increased ACF formation.
The eﬀect of these hydroimidazolone adducts in vivo is un-
known [10]. There is in vitro evidence that hydroimidazolone
formed from MG is a recognition factor for the binding of hu-
man serum albumin minimally modiﬁed with MG (MGmin-
HSA) to monocytic THP-1 cells [25]. MGmin-HSA induces
synthesis and secretion of interleukin-1b and macrophage col-
ony-stimulating factor from peripheral human monocytes
in vitro, as well as inducing tumor necrosis factor-a synthesis
and secretion from THP-1 cells [26,10]. These protein adducts
may be used as a biomarker of oxidative stress and colon car-
cinogenesis.
Scheme 1 shows a mechanism proposed for the relationship
between thiamin deﬁciency, oxidative stress (i.e., MG and gly-
oxal) and the formation of the adducts. Themechanism explains
the results of our previous in vitro study demonstrating that gly-
oxal increases cytotoxicity of isolated rat hepatocytes under thi-
amin deﬁcient conditions, assuming that the glyoxal adducts are
cytotoxic [2]. It also explains our preliminary results indicating
that marginally thiamin deﬁcient diets induce the formation of
ACF, suggesting that the glyoxal adducts can be genotoxic
and carcinogenic [18]. That is, suggesting oxidative stress can re-
duce the concentration of thiamin and that oxidative stress with
thiamin deﬁciency increases intracellular glyoxals, cytotoxicity,
5602 N. Shangari et al. / FEBS Letters 579 (2005) 5596–5602genotoxicity and carcinogenicity. This could explain the associ-
ation of oxidative stress and colon carcinogenesis in colonic
inﬂammation as in ulcerative colitis, with the consumption of
foods containing iron and heme such as meats and, perhaps,
in the carcinogenesis process itself as in ACF [27].
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